• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC INCORPORATED TIGRIS INSTRUMENT SYS-CD; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC INCORPORATED TIGRIS INSTRUMENT SYS-CD; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 105118
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/05/2021
Event Type  Injury  
Manufacturer Narrative
Final mdr.The problem in delay in injection was resolved by the hologic field service team.
 
Event Description
Initial and final report on 3/5/2021, a customer called hologic technical support (ts) to report that they had three invalid aptima hpv assay runs.Product application specialists (pas) reviewed the logs from (b)(6) 2021, date the instrument was last serviced to (b)(6) 2021.Pas found that eight different hpv worklists were potentially impacted by an auto detect (ad) delay.In three of the eight worklists from (b)(6) 2021 and (b)(6) 2021, an ad delay was noted to potentially impact hpv results; overall a total of 36 potential false positive hpv results occurred.Customer was informed, but customer decided to only retest the affected worklist ran on (b)(6) 2021.The customer was notified that additional logs from before (b)(6) 2021.Could be reviewed, however, the customer decided to not have those worklists reviewed and did not upload the logs.Field service engineer went to the customer site and resolve the delay in injection problem.Per risk assessment, the severity associated with a false positive result using the aptima hpv assay is serious.To mitigate this risk, hologic requested the customer to retest the samples in question.If the patient received a false positive result for hpv, the potential impact to the patient would be inconvenience, anxiety, and over testing.If the false positive result was obtained during repeat co-testing, a colposcopy is recommended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TIGRIS INSTRUMENT SYS-CD
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
HOLOGIC INCORPORATED
10210 genetic center drive
san diego CA 92121
Manufacturer (Section G)
HOLOGIC INC.
10210 genetic center drive
san diego 92121
Manufacturer Contact
abel saluta
10210 genetic center drive
san diego, CA 92121
8584108506
MDR Report Key11605994
MDR Text Key245850173
Report Number2024800-2021-00003
Device Sequence Number1
Product Code MKZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K003395
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 04/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue Number105118
Initial Date Manufacturer Received Not provided
Initial Date FDA Received04/01/2021
Was Device Evaluated by Manufacturer? Yes
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-